These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 26119175)

  • 1. Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.
    Hu C; Sun L; Xiao L; Han Y; Fu X; Xiong X; Xu X; Liu Y; Yang S; Liu F; Kanwar YS
    Curr Med Chem; 2015; 22(24):2858-70. PubMed ID: 26119175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling.
    Huang L; Lin T; Shi M; Chen X; Wu P
    Am J Physiol Renal Physiol; 2020 Sep; 319(3):F458-F468. PubMed ID: 32715762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.
    Qiao S; Liu R; Lv C; Miao Y; Yue M; Tao Y; Wei Z; Xia Y; Dai Y
    Free Radic Biol Med; 2019 Dec; 145():118-135. PubMed ID: 31494242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of extracellular matrix and its regulatory proteins during the process of interstitial fibrosis after anti-glomerular basement membrane antibody-induced glomerular sclerosis in Sprague-Dawley rats.
    Adhikary LP; Yamamoto T; Isome M; Nakano Y; Kawasaki K; Yaoita E; Kihara I
    Pathol Int; 1999 Aug; 49(8):716-25. PubMed ID: 10504539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.
    Ayo SH; Radnik RA; Garoni JA; Glass WF; Kreisberg JI
    Am J Pathol; 1990 Jun; 136(6):1339-48. PubMed ID: 2356864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.
    Juin SK; Pushpakumar S; Sen U
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways in diabetic nephropathy.
    Kawanami D; Matoba K; Utsunomiya K
    Histol Histopathol; 2016 Oct; 31(10):1059-67. PubMed ID: 27094540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRB3, up-regulated in kidneys of rats with type1 diabetes, mediates extracellular matrix accumulation in vivo and in vitro.
    Wang W; Sun A; Lv W; Cheng J; Lv S; Liu X; Guan G; Liu G
    Diabetes Res Clin Pract; 2014 Oct; 106(1):101-9. PubMed ID: 25112920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine].
    Yang JJ; Huang YR; Wan YG; Shen SM; Mao ZM; Wu W; Yao J
    Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(16):3125-31. PubMed ID: 26790279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of growth factors in diabetic kidney disease.
    Chiarelli F; Gaspari S; Marcovecchio ML
    Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and matrix remodeling in diabetic kidney.
    Ha H; Lee HB
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S246-9. PubMed ID: 12874440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
    Lee WJ; Liu SH; Chiang CK; Lin SY; Liang KW; Chen CH; Tien HR; Chen PH; Wu JP; Tsai YC; Lai DW; Chang YC; Sheu WH; Sheu ML
    Antioxid Redox Signal; 2016 Feb; 24(4):217-231. PubMed ID: 26415004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
    Abe H; Matsubara T; Arai H; Doi T
    Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in tubular epithelial cells in diabetic nephropathy.
    Habib SL
    J Nephrol; 2013; 26(5):865-9. PubMed ID: 24052469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.